Director, Deal Advisory
+41 58 249 58 16
Swap, don’t sell: Driving value through asset swaps
The Swiss Pharmaceuticals sector produced four USD1 billion+ deals in the first half of 2018. This is not surprising given the efforts by Pharmaceuticals and Life Sciences businesses to push new boundaries and continuously innovate.
Swiss immigration – beware of new language requirements!
New EU MDR 2020 regulations: are your apps ready?
Why EU data protection regulation also concerns Switzerland
Why a data and privacy strategy empowers genomics